AT4 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AT4; At5g55350; MTE17.6; Probable long-chain-alcohol O-fatty-acyltransferase 4; Wax synthase 4
Target Names
AT4
Uniprot No.

Target Background

Function
This antibody catalyzes the final step in the synthesis of long-chain linear esters (waxes).
Database Links

KEGG: ath:AT5G55350

STRING: 3702.AT5G55350.1

UniGene: At.62440

Protein Families
Wax synthase family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is ATF-4 antibody and what cellular processes does it target?

ATF-4 (Activating Transcription Factor 4) antibody is a research tool designed to detect and isolate the ATF-4 protein, which plays crucial roles in cellular stress responses, including the unfolded protein response and integrated stress response pathways. The antibody specifically recognizes the ATF-4 protein with a molecular weight of approximately 49 kDa. This recombinant antibody offers superior lot-to-lot consistency, continuous supply, and employs animal-free manufacturing processes .

For experimental applications, ATF-4 antibody demonstrates reactivity across multiple species including human, mouse, and rat model systems, making it versatile for comparative studies. When selecting an ATF-4 antibody for your research, consider the specific cellular compartments where ATF-4 may be localized under your experimental conditions, as translocation between cytoplasm and nucleus occurs during stress responses.

What are the primary applications of ATF-4 antibody in research settings?

The ATF-4 antibody is engineered for multiple experimental applications with validated dilution parameters for each technique:

ApplicationRecommended DilutionDetection Sensitivity
Western Blotting1:1000Endogenous levels
Immunoprecipitation1:50Endogenous levels
Immunofluorescence1:100 - 1:400Endogenous levels
Chromatin IP1:200Endogenous levels
Chromatin IP-seq1:200Endogenous levels
CUT&RUN1:200Endogenous levels
CUT&Tag1:200Endogenous levels

When implementing these techniques, researchers should consider the appropriate positive and negative controls to validate antibody specificity in their experimental system. For chromatin-based applications, the antibody has been specifically validated using SimpleChIP Enzymatic Chromatin IP Kits, CUT&RUN Assay Kit #86652, and CUT&Tag Assay Kit #77552 .

How should ATF-4 antibody validation be performed before experimental use?

Antibody validation is critical for ensuring experimental reproducibility and result reliability. A multi-faceted validation approach is recommended:

  • Specificity testing: Perform Western blot analysis comparing wild-type samples with ATF-4 knockout or knockdown samples to confirm the absence of signal in the latter.

  • Cross-reactivity assessment: Test the antibody against tissues from different species when planning cross-species experiments.

  • Batch validation: For each new lot of antibody, perform comparative analysis with previously validated lots using consistent positive control samples.

  • Functional validation: For applications beyond protein detection (such as neutralization), confirm the antibody's ability to inhibit known ATF-4 functions.

Recent literature emphasizes that enhanced validation protocols substantially improve research reproducibility. These should include at least two independent methods from: genetic knockdown, orthogonal detection methods, independent antibody verification, or recombinant expression systems .

What are the optimal sample preparation techniques for ATF-4 detection in different applications?

Sample preparation requirements vary by application:

For Western Blotting:

  • Harvest cells during appropriate stress conditions when ATF-4 is expressed

  • Lyse cells in RIPA buffer supplemented with protease inhibitors

  • Sonicate lysates briefly to shear DNA and reduce viscosity

  • Resolve approximately 30 μg of protein on 8-10% SDS-PAGE

  • Transfer to PVDF membrane and block with 5% skimmed milk powder

  • Probe with ATF-4 antibody at 1:1000 dilution

For Immunoprecipitation:

  • Use gentle lysis buffers (e.g., NP-40-based) to preserve protein-protein interactions

  • Pre-clear lysates with protein A/G beads prior to immunoprecipitation

  • Add ATF-4 antibody at 1:50 dilution and incubate overnight at 4°C

  • Capture antibody-protein complexes with appropriate beads

  • Wash thoroughly to remove non-specific interactions

For Immunofluorescence:

  • Fix cells with 4% paraformaldehyde (10-15 minutes) or methanol (at -20°C for 10 minutes)

  • Permeabilize with 0.1-0.5% Triton X-100 (if using paraformaldehyde fixation)

  • Block with appropriate serum (5-10%) to reduce background

  • Incubate with ATF-4 antibody (1:100-1:400 dilution) overnight at 4°C

  • Use appropriate fluorophore-conjugated secondary antibodies for detection

How can ATF-4 antibody be effectively employed in chromatin immunoprecipitation studies?

For chromatin immunoprecipitation (ChIP) applications, ATF-4 antibody enables researchers to identify genomic regions where ATF-4 binds to DNA, providing crucial insights into its transcriptional regulatory functions:

  • Cross-linking protocol optimization:

    • Use 1% formaldehyde for 10 minutes at room temperature for standard cross-linking

    • For transient or weak interactions, consider alternative cross-linkers or dual cross-linking approaches

    • Quench with 125 mM glycine for 5 minutes

  • Chromatin shearing parameters:

    • Aim for chromatin fragments of 200-500 bp for optimal resolution

    • Validate shearing efficiency by agarose gel electrophoresis before proceeding

    • For ATF-4 targets, sonication parameters typically include 10-15 cycles (30 seconds on/30 seconds off)

  • Immunoprecipitation conditions:

    • Use 1:200 dilution of ATF-4 antibody as validated with SimpleChIP Enzymatic Chromatin IP Kits

    • Include appropriate controls (IgG negative control and positive control for a known ATF-4 target)

    • Incubate chromatin-antibody mixture overnight at 4°C for optimal binding

  • Data analysis considerations:

    • Normalize enrichment to input samples and IgG controls

    • Validate enrichment at known ATF-4 binding sites

    • For genome-wide studies, consider using ATF-4 ChIP-seq validated dilution (1:200)

The recently developed CUT&RUN and CUT&Tag methodologies offer advantages over traditional ChIP for certain applications, with improved signal-to-noise ratios and reduced cell input requirements.

What strategies can address non-specific binding issues when using ATF-4 antibody?

Non-specific binding can significantly impact experimental results. Multiple strategies can minimize this issue:

  • Blocking optimization:

    • Test different blocking agents (BSA, normal serum, commercial blockers)

    • Increase blocking time (1-2 hours at room temperature or overnight at 4°C)

    • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

  • Antibody titration:

    • Perform dilution series to identify optimal concentration with highest signal-to-noise ratio

    • For immunoblotting, test range from 1:500 to 1:2000

    • For immunofluorescence, test range from 1:50 to 1:500

  • Washing protocol refinement:

    • Increase number of washes (minimum 3-5 washes)

    • Extend washing times (5-10 minutes per wash)

    • Include detergents at appropriate concentrations (0.1-0.5% Tween-20 or Triton X-100)

  • Pre-adsorption techniques:

    • Pre-incubate antibody with recombinant ATF-4 protein to confirm specificity

    • Use knockout/knockdown samples as negative controls

Competition assays, similar to those demonstrated with other antibodies like BG4, can validate specificity. In these assays, pre-incubation of the antibody with its target antigen should significantly reduce binding signals in subsequent detection steps .

How should experiments be designed to study ATF-4 induction under different cellular stress conditions?

ATF-4 is a critical mediator of cellular stress responses, and experimental design must account for specific stress induction parameters:

  • Endoplasmic reticulum (ER) stress induction:

    • Tunicamycin (1-5 μg/ml for 4-24 hours): inhibits N-linked glycosylation

    • Thapsigargin (100-500 nM for 4-24 hours): disrupts calcium homeostasis

    • DTT (1-2 mM for 1-4 hours): reduces disulfide bonds

  • Amino acid deprivation:

    • Incubate cells in medium lacking specific amino acids (leucine, methionine)

    • Alternatively, treat with halofuginone (50-100 nM) to mimic proline deprivation

  • Oxidative stress:

    • Hydrogen peroxide (100-500 μM for 1-6 hours)

    • Arsenite (10-50 μM for 1-4 hours)

  • Time-course considerations:

    • ATF-4 protein levels typically peak between 2-8 hours after stress induction

    • Include multiple time points to capture the dynamic response

    • For transient transfection studies, analyze 24-48 hours post-transfection

For rigorous experimental design, include appropriate positive controls (known inducers of ATF-4) and negative controls (conditions where ATF-4 should not be induced). When analyzing results, quantify band intensity for Western blots by selecting identical rectangular areas in each lane, subtracting background, and normalizing to loading controls like β-actin .

What considerations are important when using ATF-4 antibody in multiplex immunofluorescence applications?

Multiplex immunofluorescence allows simultaneous detection of multiple proteins, providing insights into co-localization and pathway interactions:

  • Antibody compatibility validation:

    • Ensure primary antibodies originate from different host species (e.g., rabbit ATF-4 with mouse antibodies for other targets)

    • Test each antibody individually before combining to confirm specific staining patterns

    • Verify that secondary antibodies do not cross-react with non-target primary antibodies

  • Spectral separation optimization:

    • Choose fluorophores with minimal spectral overlap to reduce bleed-through

    • For ATF-4 (which may give relatively weak signals), assign brightest fluorophores

    • Include single-stained controls for spectral unmixing calibration

  • Signal amplification strategies:

    • For weak ATF-4 signals, consider tyramide signal amplification (TSA)

    • Biotin-streptavidin systems can enhance sensitivity

    • Balance amplification with potential increases in background

  • Co-localization analysis parameters:

    • Use appropriate software (ImageJ with JACoP plugin, CellProfiler)

    • Calculate Pearson's correlation coefficient and Mander's overlap coefficient

    • Set threshold values based on control samples

When performing immunofluorescence with ATF-4 antibody, optimal dilution ranges from 1:100 to 1:400, but this should be empirically determined for each experimental system and when used in combination with other antibodies .

How can quantitative analysis of ATF-4 antibody signals be standardized across different experimental platforms?

Standardization of quantitative analysis ensures reproducibility and comparability across experiments:

  • Western blot quantification:

    • Use digital imaging systems with linear dynamic range

    • Include standard curve of recombinant ATF-4 protein when absolute quantification is needed

    • Normalize target bands to housekeeping proteins (β-actin, GAPDH) expressed as ratio

    • Report PSLU (Photon Stimulated Light Units) values after background subtraction

  • Immunofluorescence quantification:

    • Standardize image acquisition parameters (exposure time, gain, offset)

    • Implement flat-field correction to address illumination heterogeneity

    • Measure nuclear vs. cytoplasmic signal intensities separately

    • Report data as mean fluorescence intensity or integrated density values

  • ChIP data normalization:

    • Express enrichment as percentage of input or fold enrichment over IgG control

    • For ChIP-seq data, use spike-in controls for between-sample normalization

    • Apply appropriate peak calling algorithms with consistent parameters

  • Inter-laboratory standardization:

    • Include common reference samples across experiments

    • Document detailed protocols including lot numbers of reagents

    • Participate in antibody validation initiatives similar to those for other antibodies like BG4

When comparing results across different detection methods, consider inherent sensitivity differences between techniques. For instance, immunoblotting may detect global protein level changes, while immunofluorescence provides spatial information but may have different detection thresholds.

What are the best methods for discriminating between specific and non-specific signals when using ATF-4 antibody?

Discrimination between specific and non-specific signals requires rigorous validation strategies:

  • Genetic validation approaches:

    • Compare signals between wild-type and ATF-4 knockout/knockdown samples

    • Use CRISPR/Cas9-mediated knockout for complete elimination of target

    • For transient validation, implement siRNA or shRNA approaches with approximately 48-hour post-transfection analysis

  • Epitope competition assays:

    • Pre-incubate antibody with excess recombinant ATF-4 protein

    • Observe elimination or significant reduction of specific signals

    • Include gradient of competing antigen to demonstrate dose-dependency

  • Orthogonal method validation:

    • Confirm results using alternative detection methods

    • Correlate protein detection with mRNA levels (RT-qPCR)

    • Verify with alternative antibodies targeting different epitopes

  • Statistical approaches for signal discrimination:

    • Implement appropriate background correction algorithms

    • Use triplicate technical and biological replicates

    • Apply stringent statistical thresholds (e.g., p<0.05 with appropriate multiple testing correction)

Learning from BG4 antibody validation studies, researchers can implement competition experiments where fixed concentrations of ATF-4 antibody are incubated with labeled target, followed by addition of increasing concentrations of unlabeled target. Specific binding should show significant reduction in signal as unlabeled target concentration increases, while random sequences should not compete for binding .

How can ATF-4 antibody be effectively integrated into CUT&RUN and CUT&Tag chromatin profiling technologies?

CUT&RUN and CUT&Tag represent cutting-edge chromatin profiling technologies that offer advantages over traditional ChIP, including reduced background, lower input requirements, and improved resolution:

  • CUT&RUN implementation with ATF-4 antibody:

    • Use recommended 1:200 dilution with validated CUT&RUN Assay Kit #86652

    • Optimize digitonin concentration (typically 0.01-0.05%) for cell permeabilization

    • Allow 2-4 hours for antibody binding at 4°C

    • Include positive control antibody (H3K4me3) and negative control (IgG)

  • CUT&Tag protocol adaptations:

    • Follow recommended 1:200 dilution with CUT&Tag Assay Kit #77552

    • For low abundance factors like ATF-4, extend antibody incubation to overnight

    • Confirm tagmentation efficiency using qPCR before sequencing

    • Target 5-10 million reads per sample for adequate coverage

  • Bioinformatic analysis considerations:

    • Use spike-in normalization for quantitative comparisons

    • Implement peak calling algorithms optimized for CUT&RUN/CUT&Tag data

    • Compare with published ATF-4 ChIP-seq datasets for validation

    • Perform motif enrichment analysis to confirm presence of known ATF-4 binding sites

  • Integration with other genomic datasets:

    • Correlate ATF-4 binding with gene expression data

    • Integrate with chromatin accessibility (ATAC-seq) data

    • Examine co-localization with histone modifications associated with active/repressed chromatin

The high sensitivity of these methods makes them particularly valuable for studying condition-specific transcription factor binding, such as ATF-4 recruitment during various stress conditions.

What are the considerations for using ATF-4 antibody in single-cell protein analysis techniques?

Single-cell protein analysis provides insights into cellular heterogeneity that bulk methods cannot capture:

  • Flow cytometry optimization:

    • Improve antibody penetration with optimized fixation/permeabilization

    • Use saponin (0.1-0.3%) for reversible permeabilization

    • Implement indirect detection with fluorophore-conjugated secondary antibodies

    • Include appropriate compensation controls for multiparameter analysis

  • Mass cytometry (CyTOF) applications:

    • Conjugate ATF-4 antibody with rare earth metals

    • Validate metal-conjugated antibody against unconjugated version

    • Design panel to include upstream regulators and downstream targets of ATF-4

    • Apply dimensionality reduction techniques (tSNE, UMAP) for visualization

  • Single-cell Western blot considerations:

    • Optimize cell settling time and density on microwell arrays

    • Adjust UV exposure for optimal protein immobilization

    • Determine optimal antibody concentration (typically higher than conventional Western blot)

    • Implement rigorous background correction algorithms

  • Imaging mass cytometry adaptations:

    • Balance antibody concentration for sufficient signal without background

    • Optimize laser ablation parameters for cellular resolution

    • Implement nuclear counterstaining for accurate cell segmentation

    • Use unsupervised clustering to identify cell populations with distinct ATF-4 expression patterns

When analyzing ATF-4 at the single-cell level, consider that stress responses might not be synchronous across a population, resulting in heterogeneous expression patterns that require careful statistical analysis and interpretation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.